TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization
Clinical Science · 2025
DOI: 10.1042/cs20255833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2025. Verfasst von Shengbiao Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Nucleic Acid Medicine of Luzhou Key Laboratory, Basic Medicine Research Innovation Center for Cardiometabolic Disea…. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Tetraspanins, Myocytes, Smooth Muscle, Tropomyosin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan Province, Applied Basic Research Program of Sichuan Province, Science and Technology Project of Luzhou Government.
Abstract (Originalsprache)
Vascular smooth muscle cell (VSMC) phenotypic switching, followed by enhanced proliferation and migration, is a key event in the development of intimal hyperplasia in diverse vascular diseases. While tetraspanin 4 (TSPAN4) is known to be expressed in the vasculature, its function in VSMC phenotypic switching and vascular disease is currently unknown. Here, we investigated the role of TSPAN4 using an in vitro model of platelet-derived growth factor BB (PDGF-BB)-induced phenotypic switching and an in vivo carotid artery ligation model in wildtype and TSPAN4-deficient mice. Our experiments, including EdU assays, Transwell assays, western blot analysis, and immunoprecipitation, revealed that TSPAN4 expression is elevated in human atherosclerotic arteries, ligated mouse carotid arteries, and PDGF-BB-stimulated VSMCs. Additionally, TSPAN4 overexpression promoted the switch from a contractile to a synthetic phenotype, accompanied by enhanced VSMC proliferation and migration. Conversely, TSPAN4 knockdown inhibited these effects, suppressing PDGF-BB-induced phenotypic switching. Mechanistically, TSPAN4 was found to interact with and influence the expression and localization of tropomyosin-1 (TPM1). This, in turn, affected cytoskeletal organization, ultimately driving phenotypic switching and functional alterations in VSMCs. Finally, we demonstrated that TSPAN4 deficiency in mice attenuated vascular neointimal formation following carotid artery ligation. These findings suggested that TSPAN4 is a promising novel therapeutic target for vascular remodeling and proliferative vascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Nucleic Acid Medicine of Luzhou Key Laboratory, Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Southwest Medical University, Luzhou, Sichuan, 646000, China.
- Department of Cardiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Nucleic Acid Medicine of Luzhou Key Laboratory, Key Laboratory of Medical Electrophysiology, Ministry of Education, Institute of Cardiov…
- Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education; Luzhou Municipal Key Laboratory of Thrombosis and Vascular Biology; Laboratory for Cardiovascular Pharmacology, Department o…
- Department of Pharmacology, School of Pharmacy, Nucleic Acid Medicine of Luzhou Key Laboratory, Central Nervous System Drug Key Laboratory of Sichuan Province, Southwest Medical University, Luzhou, Sichuan, 646000, Chin…
- Anesthesiology and Critical Care Medicine Key Laboratory of Luzhou, the Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.
ORCID-Profile: Shengbiao Li, Chunxiang Zhang
Förderung
- Natural Science Foundation of Sichuan Province
- Applied Basic Research Program of Sichuan Province
- Science and Technology Project of Luzhou Government
- Southwest Medical University
- Sichuan Province Science and Technology Support Program
- National Natural Science Foundation of China
- The Central Government Guides Local Science and Technology Development Project
- Research Start-up Foundation of Southwest Medical University
Zitieren
APA
Li, S., Chen, K., Zhang, Y., Yu, Y., Zhang, T., Jiang, D., Li, M., Fu, S., Chen, J., Li, J., Yi, J., Li, R., Qiao, G., Feng, J., Jiang, J., Yuan, Q., & Zhang, C. (2025). TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization. Clinical Science. https://doi.org/10.1042/cs20255833
Vancouver
Li S, Chen K, Zhang Y, Yu Y, Zhang T, Jiang D, et al. TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization. Clinical Science. 2025. doi:10.1042/cs20255833
BibTeX
@article{Li2025,
author = {Li, Shengbiao and Chen, Kexin and Zhang, Yi and Yu, Yang and Zhang, Tianyi and Jiang, Donghui and Li, Mi and Fu, Shubo and Chen, Ji and Li, Jiapan and Yi, Jingyan and Li, Rong and Qiao, Gan and Feng, Jianguo and Jiang, Jun and Yuan, Qiong and Zhang, Chunxiang},
title = {TSPAN4 controls vascular smooth muscle cell phenotypic switching and intimal hyperplasia by targeting TPM1-regulated cytoskeletal organization},
journal = {Clinical Science},
year = {2025},
doi = {10.1042/cs20255833}
}
EUVIMED